Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
Completed · Phase 3 · Has a placebo group
Conditions studied: Carcinoma, Squamous Cell of the Head and Neck
In brief
The purpose of this Phase 3 study is to evaluate overall survival and progression free survival following intravenous administration of REOLYSIN (Reovirus Serotype 3 Dearing) in combination with paclitaxel and carboplatin versus chemotherapy treatment alone, in patients with metastatic or recurrent Squamous Cell Carcinoma of the Head and Neck.
Key facts
- Study ID
- NCT01166542
- Run by
- Oncolytics Biotech
- People needed
- 167
- Starts
- 2010-06-01
- Expected to finish
- 2014-05-01
- Last updated by the study team
- 2014-11-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arizona Oncology Associates — Tucson, Arizona, United States
- Providence Health and Services — Burbank, California, United States
- Wilshire Oncology Medical Group — Corona, California, United States
- BMS Physician Practice, A Medical Corporation DBA Medical Oncology Care Associates — Orange, California, United States
- Rocky Mountain Cancer Centers — Denver, Colorado, United States
- Pasco Hernando Oncology Associates, PA — New Port Richey, Florida, United States
- Emory University - Winship Cancer Institute — Altanta, Georgia, United States
- Alexian Brothers Hospital Network — Elk Grove Village, Illinois, United States
- Mary Bird Perkinds Cancer Center - Baton Rouge — Baton Rouge, Louisiana, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada, United States
- Montefiore Medical Center — The Bronx, New York, United States
- Case Comprehensive Cancer Center, University Hospitals Case Medical Center — Cleveland, Ohio, United States
- Mercy Cancer Center — Toledo, Ohio, United States
- Medical University of South Carolina — Charleston, South Carolina, United States
- Texas Oncology- Sammons Cancer Center — Dallas, Texas, United States
- Cancer Therapy and Research Center at UTHSCSA — San Antonio, Texas, United States
- Texas Oncology - Tyler — Tyler, Texas, United States
- Columbia Basin Hematology and Oncology — Kennewick, Washington, United States
- ZNA Middelheim — Antwerp, Belgium
- University Hospital Antwerp — Edegem, Belgium
- Universitair Ziekenhuis Brussel — Jette, Belgium
- Tom Baker Cancer Centre — Calgary, Alberta, Canada
- University of Alabama at Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.